Investors Forum |
A community of New Zealand investors |
|
|
#1 (permalink) |
|
Senior Member
Join Date: Dec 2006
Posts: 35,505
|
Auckland-based Neuren Pharmaceuticals has bought a US drug company to target a multibillion-dollar market for treating post-stroke depression.The purchase of Washington DC-based Hamilton Pharmaceuticals for $4.4 million will get...
More... |
|
|
|
| Tags |
| market |
| Thread Tools | |